Access To Treatment
Over the past three decades, DKMS has grown to become an international and multifaceted organization, one that is able to fight life-threatening blood diseases from many different angles by employing a wide range of programs and services. Access To Treatment (ATT) complements DKMS’ activities in donor recruitment, science and research by addressing another crucial challenge: ensuring that more patients can access the treatment they need.
About Access To Treatment
Improving the situation of patients living in low- and middle-income countries
We firmly believe that giving as many patients as possible a second chance at life requires a holistic approach. Access To Treatment offers several programs for low- and middle-income countries and collaborates with non-profit organizations who are pursuing the same cause. While stem cell transplantation remains a core focus of our work, we increasingly support the entire patient journey: from creating the conditions needed for treatment to follow-up care.
We help where help is needed
We believe it is crucial to remove both socio-economic and infrastructural barriers so that more patients are able to access potentially lifesaving therapy. At DKMS, we are committed to alleviating these barriers and continuously strive to find new ways to facilitate access to treatment and save as many lives as possible.
“For the second chance at life, we cross borders, collaborate globally and leave no stone unturned to help patients. Every patient with blood cancer or a life-threatening blood disease such as thalassemia or sickle cell disease deserves that chance. Thus, we have established several programs to improve the situation of such patients, particularly those living in resource-constrained regions of the world,” says Dr. Elke Neujahr, Global CEO DKMS.
Our areas of activity
Our activities to facilitate access to treatment cover three main areas:
DKMS Patient Funding Program
The DKMS Patient Funding Program aims to lessen financial barriers to transplantation by contributing to treatment costs for patients who would otherwise not receive treatment.
DKMS Free HLA Typing Program
The DKMS Free HLA Typing Program supports the identification of suitable family donors by covering HLA typing costs for patients in need of a transplant and their family members. We also support unrelated donor searches for patients who do not find a suitable family donor.
DKMS Capacity-Building Program
The DKMS Capacity Building Program advances treatment and care through infrastructural support and knowledge sharing. This includes supporting treatment capacities as well as the training and education of healthcare professionals.
Learn more about our Programs:
